Nathalie Layios
-
- Nosocomial Infections in ICU 6
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
-
- Sepsis Diagnosis and Treatment 7
- Pneumonia and Respiratory Infections 5
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Respiratory Support and Mechanisms 4
-
- Immune Response and Inflammation 3
-
- Antifungal resistance and susceptibility 2
- Co-authors
- Frédéric FrippiatBernard LambermontPierre DamasMonique NysPatrizio LancellottiDidier LedouxJulie DescyPhilippe Morimont
- Cited by
- Critical Care and Intensive Care MedicineApplied Microbiology and BiotechnologyMolecular Medicine
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)Critical Care Medicine (2 papers)
- Partner nations
- BelgiumAustraliaUnited States
In The Last Decade
Nathalie Layios
22 papers receiving 350 citations
Peers
Comparison fields: 5 of 58
- Critical Care and Intensive Care Medicine 161
- Applied Microbiology and Biotechnology 54
- Molecular Medicine 61
- Epidemiology 190
- Pharmacology 83
Countries citing papers authored by Nathalie Layios
This map shows the geographic impact of Nathalie Layios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Layios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Layios more than expected).
Fields of papers citing papers by Nathalie Layios
This network shows the impact of papers produced by Nathalie Layios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Layios. The network helps show where Nathalie Layios may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nathalie Layios, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 29 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 27 | |
| 11 | 2017 | 22 | |
| 12 | 2014 | 54 | |
| 13 | 2014 | 84 | |
| 14 | 2013 | 4 | |
| 15 | 2013 | 3 | |
| 16 | 2012 | 93 | |
| 17 | 2011 | 8 | |
| 18 | Usefulness of procalcitonin for the decision of antibiotic treatment in ICU patients | 2009 | 2 |
| 19 | Renal failure and ICU-acquired infection | 2008 | 1 |
| 20 | 2004 | 14 |
About Nathalie Layios
Nathalie Layios is a scholar working on Critical Care and Intensive Care Medicine, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 24 papers that have together received 357 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (7 papers), Nosocomial Infections in ICU (6 papers), Pneumonia and Respiratory Infections (5 papers), Antibiotic Resistance in Bacteria (4 papers), Respiratory Support and Mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Immune Response and Inflammation (3 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (161 citations), Applied Microbiology and Biotechnology (54 citations) and Molecular Medicine (61 citations). Nathalie Layios has collaborated with scholars based in Belgium, Australia and United States. Frequent co-authors include Frédéric Frippiat, Bernard Lambermont, Pierre Damas, Monique Nys, Patrizio Lancellotti, Didier Ledoux, Julie Descy, Philippe Morimont, Sonia Piret and Paul Massion. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.